AIM
NVIV

Advantage Investment Management’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Advantage Investment Management’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Hold
0
– – – 990
2019
Q2 		– Hold
0
– – – 990
2019
Q1 		– Hold
0
– – – 1048
2018
Q4 		– Hold
0
– – – 1134
2018
Q3 		– Hold
0
– – – 1109
2018
Q2 		– Hold
0
– – – 1076
2018
Q1 		– Hold
0
– – – 987
2017
Q4 		– Hold
0
– – – 989
2017
Q3 		– Hold
0
– – – 1015
2017
Q2 		– Hold
0
– – – 935
2017
Q1 		– Hold
0
– – – 846
2016
Q4 		– Hold
0
– – – 793
2016
Q3 		– Hold
0
– – – 693

Other funds holding NVIV

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PWM
Paulson Wealth Management Wheaton, Illinois $427M AUM 16.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NCM
Next Capital Management New York $330M AUM 11.54% 1-Year Est. Return